Corporate Governance
Good governance is an important factor in the effective management of Angiotech's operations. Shareholders expect, and are entitled to, a Board that capably represents their interests in overseeing management. The Company's Board of Directors currently consists of five independent members and one executive member. The role of Chair is assumed by an independent director and is separate from the role of Chief Executive Officer. Independent directors also chair the two committees of the Board. Each director brings unique experiences and skills in providing oversight and governance. All committees consist of independent directors.
Angiotech's Board of Directors
Click on the director's name to read a corresponding biography.
- David T. Howard, Chairman of the Board
- William L. Hunter, President & CEO
- Hank McKinnell
- Ned Brown
- Arthur H. Willms
- Laura A. Brege
Codes of Ethics
- Guide of Business Conduct
- Code of Ethics for the Chief Executive Officer, Chief Financial Officer and SVP Finance
Committee Charters
- Corporate Governance Guidelines
- Governance, Nominating and Compensation Committee Charter
- Audit Committee Charter
Read more about Angiotech's Management Team
Investors
- Investor Overview
- Corporate Governance
- Events & Webcasts
- Quarterly Results
- Proxy Materials
- SEC Filings
- Request Information
Quick Links
© Copyright 2010 Angiotech. All Rights Reserved.